X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs SUVEN LIFE - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD SUVEN LIFE BIOCON LTD/
SUVEN LIFE
 
P/E (TTM) x 80.9 17.2 470.4% View Chart
P/BV x 6.9 3.6 193.1% View Chart
Dividend Yield % 0.2 0.6 26.3%  

Financials

 BIOCON LTD   SUVEN LIFE
EQUITY SHARE DATA
    BIOCON LTD
Mar-18
SUVEN LIFE
Mar-18
BIOCON LTD/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs1,188251 473.7%   
Low Rs305155 196.8%   
Sales per share (Unadj.) Rs68.749.1 139.9%  
Earnings per share (Unadj.) Rs7.69.7 77.7%  
Cash flow per share (Unadj.) Rs14.011.4 122.6%  
Dividends per share (Unadj.) Rs1.001.50 66.7%  
Dividend yield (eoy) %0.10.7 18.1%  
Book value per share (Unadj.) Rs86.360.3 143.2%  
Shares outstanding (eoy) m600.00127.28 471.4%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.94.1 263.0%   
Avg P/E ratio x98.920.9 473.4%  
P/CF ratio (eoy) x53.417.8 300.0%  
Price / Book Value ratio x8.63.4 256.9%  
Dividend payout %13.215.4 85.8%   
Avg Mkt Cap Rs m447,90025,825 1,734.4%   
No. of employees `0006.11.1 573.6%   
Total wages/salary Rs m9,311613 1,519.7%   
Avg. sales/employee Rs Th6,705.85,832.6 115.0%   
Avg. wages/employee Rs Th1,514.2571.5 264.9%   
Avg. net profit/employee Rs Th736.91,153.8 63.9%   
INCOME DATA
Net Sales Rs m41,2346,253 659.5%  
Other income Rs m2,062233 886.1%   
Total revenues Rs m43,2966,485 667.6%   
Gross profit Rs m8,2911,982 418.4%  
Depreciation Rs m3,851213 1,807.1%   
Interest Rs m61546 1,328.3%   
Profit before tax Rs m5,8871,955 301.1%   
Minority Interest Rs m2130-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,569718 218.4%   
Profit after tax Rs m4,5311,237 366.3%  
Gross profit margin %20.131.7 63.4%  
Effective tax rate %26.736.7 72.5%   
Net profit margin %11.019.8 55.5%  
BALANCE SHEET DATA
Current assets Rs m41,4865,622 737.9%   
Current liabilities Rs m21,4131,168 1,833.9%   
Net working cap to sales %48.771.2 68.3%  
Current ratio x1.94.8 40.2%  
Inventory Days Days6481 78.6%  
Debtors Days Days9436 262.1%  
Net fixed assets Rs m50,6613,325 1,523.8%   
Share capital Rs m3,000127 2,356.6%   
"Free" reserves Rs m48,8087,547 646.7%   
Net worth Rs m51,8087,674 675.1%   
Long term debt Rs m17,89814 128,762.6%   
Total assets Rs m99,8979,135 1,093.5%  
Interest coverage x10.643.2 24.5%   
Debt to equity ratio x0.30 19,073.1%  
Sales to assets ratio x0.40.7 60.3%   
Return on assets %5.214.0 36.7%  
Return on equity %8.716.1 54.3%  
Return on capital %9.626.0 37.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,0585,066 238.0%   
Fx outflow Rs m7,3482,001 367.2%   
Net fx Rs m4,7103,065 153.7%   
CASH FLOW
From Operations Rs m6,621699 946.7%  
From Investments Rs m-6,840-6 112,131.1%  
From Financial Activity Rs m-2,397-577 415.4%  
Net Cashflow Rs m-2,612116 -2,245.9%  

Share Holding

Indian Promoters % 40.4 63.4 63.7%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 0.0 -  
FIIs % 10.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 36.5 54.5%  
Shareholders   109,995 37,287 295.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   PIRAMAL ENTERPRISES  GSK PHARMA  DR. DATSONS LABS  DR. REDDYS LAB  NOVARTIS  

Compare BIOCON LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 284 Points Up; FMCG & Metal Stocks Top Gainers(Closing)

Indian share markets settled higher today taking cues from their Asian peers. At the closing bell, BSE Sensex ended up by 284 points.

Related Views on News

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, BIOCON LTD has posted a net profit of Rs 1 bn (up 47.2% YoY). Sales on the other hand came in at Rs 11 bn (up 20.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Banks are Raising FD Rates and That's Good News(Vivek Kaul's Diary)

Aug 7, 2018

Lending to the retail segment remains strong, whereas lending to the service sector has picked up dramatically.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Aug 17, 2018 (Close)

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE BIOCON LTD WITH

MARKET STATS